Similar to findings in clinical HCC samples, there was no significant change in SAMHD1 protein and mRNA levels in tumor tissues compared with liver lysates from vehicle‐treated control mice (Figure 2D–F). The gene discussed is SAMHD1; the disease is hepatocellular carcinoma.